SCHEMBL5359991

SCHEMBL5359991

OCCC/C=C/c1nn(Cc2ccc(Cl)cc2Cl)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
PMP22 Q01453 1/20 0.38
HIF1A Q16665 1/20 0.38
ENPP2 Q13822 2/20 0.37
TRPV1 Q8NER1 1/20 0.37
EPHX2 P34913 2/20 0.36
F2RL3 Q96RI0 3/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC16A3 O15427 2/20 0.34
SLC16A1 P53985 2/20 0.34
MCTS1 Q9ULC4 2/20 0.34
NPC1 O15118 1/20 0.34
PPARG P37231 2/20 0.33
MARS1 P56192 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5359999 1.00 NPSR1 (0.38) NPSR1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5348942 0.94 CYP1A2 (0.39) NPSR1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5348946 0.94 CYP1A2 (0.39) NPSR1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5333741 0.92 F2RL3 (0.37) CYP1A2CYP3A4CYP2D6CYP2C9ENPP2
SCHEMBL5337868 0.92 ENPP2 (0.38) CYP2D6CYP2C9ENPP2F2RL3PPARG
SCHEMBL5337864 0.92 ENPP2 (0.38) CYP2D6CYP2C9ENPP2F2RL3PPARG
SCHEMBL5333744 0.92 F2RL3 (0.37) CYP1A2CYP3A4CYP2D6CYP2C9ENPP2
SCHEMBL5376297 0.91 ENPP2 (0.36) CYP1A2CYP3A4CYP2D6CYP2C9ENPP2
SCHEMBL5376294 0.91 ENPP2 (0.36) CYP1A2CYP3A4CYP2D6CYP2C9ENPP2
SCHEMBL5318939 0.91 CYP1A2 (0.40) NPSR1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed